Influence of Shorter Duration of Prophylactic Antibiotic Use on the Incidence of Surgical Site Infection Following Colorectal Cancer Surgery

Annals of Coloproctology
Youn Young ParkSuk-Hwan Lee

Abstract

This study aimed to identify the risk factors for surgical site infections (SSIs) in patients undergoing colorectal cancer surgery and to determine whether significantly different SSI rates existed between the short prophylactic antibiotic use group (within 24 hours) and the long prophylactic antibiotic use group (beyond 24 hours). The medical records of 327 patients who underwent colorectal resection due to colorectal cancer from January 2010 to May 2014 at a single center were retrospectively reviewed, and their characteristics as well as the surgical factors known to be risk factors for SSIs, were identified. Among the 327 patients, 45 patients (13.8%) developed SSIs. The patients were divided into two groups according to the duration of antibiotic use: group S (within 24 hours) and group L (beyond 24 hours). Of the 327 patients, 114 (34.9%) were in group S, and 213 (65.1%) were in group L. Twelve patients (10.5%) in group S developed SSIs while 33 patients (15.5%) in group L developed SSIs (P = 0.242). History of diabetes mellitus and lung disease, long operation time, and perioperative transfusion were independent risk factors for SSIs. This study shows that discontinuation of prophylactic antibiotics within 24 hours after...Continue Reading

References

Nov 11, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S L GorbachR L Nichols
Jul 1, 1989·The Journal of Surgical Research·E S HansenF Gottrup
May 1, 1973·The British Journal of Surgery·R C Burton
Sep 25, 1997·Archives of Surgery·D B AllenT K Hunt
Aug 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R P GaynesJ S Tolson
Jul 26, 2003·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·J KondrupUNKNOWN Educational and Clinical Practice Committee, European Society of Parenteral and Enteral Nutrition (ESPEN)
Mar 31, 2005·Annals of Surgery·Lars Tue SørensenTorben Jørgensen
Apr 12, 2005·American Journal of Surgery·Dale W BratzlerUNKNOWN Surgical Infection Prevention Guideline Writers Workgroup
May 26, 2006·International Wound Journal·David J LeaperAnne Berger
Aug 30, 2008·Circulation·Bernard I LevyHarry A J Struijker-Boudier
Jan 8, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·W Matthew LinamBeverly L Connelly
Dec 17, 2009·American Journal of Infection Control·Jonathan R EdwardsTeresa C Horan
Apr 15, 2010·Diseases of the Colon and Rectum·Carlos PastorJulio Garcia-Aguilar
Dec 3, 2010·Journal of the American College of Surgeons·Rishabh SehgalWalter A Koltun
Jan 19, 2013·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Dale W BratzlerUNKNOWN Society for Healthcare Epidemiology of America

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation

Software Mentioned

PASW Statistics

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.